Cargando…
Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin
It is unknown how rifampicin resistance in staphylococci causing a periprosthetic joint infection (PJI) affects outcomes after debridement, antibiotics, and implant retention (DAIR). We thus aimed to compare the risk of relapse in DAIR-treated early PJI caused by staphylococci with or without rifamp...
Autores principales: | Eriksson, Hannah K., Lazarinis, Stergios, Järhult, Josef D., Hailer, Nils P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668653/ https://www.ncbi.nlm.nih.gov/pubmed/37998791 http://dx.doi.org/10.3390/antibiotics12111589 |
Ejemplares similares
-
Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients
por: Lazarinis, Stergios, et al.
Publicado: (2023) -
1210. Staphylococcal Acute Post-Operative Prosthetic Joint Infection (PJI) Treated With “DAIR” (Debridement and Implant Retention) and Impact of Rifampin: A Retrospective Cohort Study in France
por: Becker, Agathe, et al.
Publicado: (2018) -
1306. Lower Treatment Failure Rates in Patients with Non-Staphylococcal Prosthetic Joint Infections (PJI) Treated with Debridement and Implant Retention (DAIR) Receiving Chronic Antibiotic Suppression (CAS)
por: Sekar, Poorani, et al.
Publicado: (2023) -
Risk factors affect success rate of debridement, antibiotics and implant retention (DAIR) in periprosthetic joint infection
por: Xu, Yihong, et al.
Publicado: (2020) -
Development of an innovative in vivo model of PJI treated with DAIR
por: Poilvache, Hervé, et al.
Publicado: (2022)